Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Molecular and Cellular Biochemistry|July 11, 2015
Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot studyIsabel Pérez-Núñez, José L Pérez-Castrillón, María T Zarrabeitia, et al.The Annals of Pharmacotherapy|April 14, 2026
Erenumab and Galcanezumab for Chronic Migraine Refractory to OnabotulinumtoxinA: A Real-World Comparative StudySara Martín-Yeves, Ana Colón-López de Dicastillo, Javier Riancho, et al.Journal of Alzheimer'S Disease : JAD|May 2, 2018
Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory UnitsCarmen Lage, Andrea Gonzalez Suarez, Ana Pozueta, et al.Frontiers in Immunology|February 23, 2023
Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot studyPilar Santiago-Setien, Cristina Barquín-Rego, Paula Hernández-Martínez, et al.Journal of Alzheimer'S Disease : JAD|September 29, 2019
A Brief Drawing Task for the Differential Diagnosis of Semantic DementiaAna Pozueta, Carmen Lage, María García Martínez, et al.Journal of Alzheimer'S Disease : JAD|November 6, 2019
Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's DiseaseAna Pozueta, Carmen Lage, María García-Martínez, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 29, 2020
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosisGorka FernÁndez-Eulate, JosÉ Ignacio Ruiz-Sanz, Javier Riancho, et al.European Journal of Neurology|December 9, 2022
Characterizing SOD1 mutations in Spain. The impact of genotype, age, and sex in the natural history of the diseaseJuan F Vázquez-Costa, Daniel Borrego-Hernández, Carmen Paradas, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|May 4, 2020
A snake that bites its own tail. Acquisition and loss of concepts in children and semantic dementia patients through the analysis of drawingsAna Pozueta, Carmen Lage, María García-Martínez, et al.International Journal of Molecular Sciences|June 12, 2026
Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple SclerosisLucienne Costa-Frossard, Luis Brieva, Daniel Apolinar García-Estévez, et al.Pageof 6